{"symbol":"LLY","fiscalQuarter":"Q4-2019","reportDate":"2020-01-30","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2019","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Up 1.97%","keyNumbers":[{"metric":"EPS","actual":"$1.73","expected":"N/A","surprise":"+11.87%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Eli Lilly's earnings report shows a strong performance in EPS, exceeding expectations by nearly 12%. The stock reacted positively, rising by almost 2%. However, without revenue figures or management commentary, investors may have limited insight into the company's overall performance and future outlook.","metaDescription":"Eli Lilly (LLY) Q4 2019 earnings: EPS beat by 11.87%. Stock up 1.97%. Full breakdown."}}